Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Glioblastoma 7Urinary Bladder Neoplasms 5Lung Neoplasms 5Glioma 5Breast Neoplasms 5Esophageal Neoplasms 4Burkitt Lymphoma 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Carcinoma 3Sarcoma, Ewing 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Mouth Neoplasms 2Mesothelioma, Malignant 2Medulloblastoma 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Gliosarcoma 2Ganglioneuroblastoma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Astrocytoma 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

Paclitaxel 3Oxaliplatin 3Leucovorin 3Fluorouracil 3Docetaxel 3Capecitabine 3zolbetuximab 2trastuzumab deruxtecan 2pembrolizumab 2enzalutamide 2darolutamide 2Ramucirumab 2Nivolumab 2Irinotecan 2trifluridine tipiracil drug combination 1repotrectinib 1regorafenib 1lenvatinib 1ipatasertib 1fludarabine 1durvalumab 1atezolizumab 1apalutamide 1aldesleukin 1abiraterone 1X-Rays 1Vinorelbine 1Trifluridine 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × Radiation × 30 days × Clear all
NCT03132922 2026-06-04

MAGE-A4ᶜ¹º³²T for Multi-Tumor

USWM, LLC (dba US WorldMeds)

Phase 1 Active not recruiting
71 enrolled 20 charts
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡